2015
DOI: 10.1179/2047480615z.000000000289
|View full text |Cite
|
Sign up to set email alerts
|

Using social media as the patient's voice in the benefit-risk assessment of drugs: Are we ready?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…MAHs may ‘listen to’ user-generated content from key healthcare opinion leaders or patient group representatives for a defined period of time [ 36 ]. Other examples are patient-reported outcomes from web-based sources, which are becoming increasingly important since they provide opportunities for pharmaceutical industry and medicines regulators to understand the benefits and risks of medicines in a real-world context [ 15 ]. These trends are indicative of an increasing use of social media to support safety monitoring and for which a regulatory framework is needed (see Sect.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…MAHs may ‘listen to’ user-generated content from key healthcare opinion leaders or patient group representatives for a defined period of time [ 36 ]. Other examples are patient-reported outcomes from web-based sources, which are becoming increasingly important since they provide opportunities for pharmaceutical industry and medicines regulators to understand the benefits and risks of medicines in a real-world context [ 15 ]. These trends are indicative of an increasing use of social media to support safety monitoring and for which a regulatory framework is needed (see Sect.…”
Section: Discussionmentioning
confidence: 99%
“…The use of social media and associated regulatory challenges are becoming widely discussed. Whilst some experts believe that monitoring of the safety of medicines via social media could prove to be an efficient and expeditious means of post-market safety surveillance overcoming limitations of traditional ADR reporting systems [ 14 ], others stress that ADR reporting methodologies could add social media as a source of information for the benefit–risk evaluation of medicines [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…17 Traditional research on beliefs and attitudes relies on surveys, 18,19 interviews, or focus groups. 9 However, social media may allow the patient voice to be heard 20 as well as provide additional data from a wider patient perspective and include patients reluctant to participate in research. In addition, social media posts can be collected in almost real time and are spontaneous; thus, they may be more likely to reflect true beliefs than research, which relies on interrogation.…”
Section: Introductionmentioning
confidence: 99%